SPRB — Spruce Biosciences Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMicro CapNeutral

Annual balance sheet for Spruce Biosciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	3.92	157	89	79.1	96.3
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4.65	160	91.9	83.6	102
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	1.79	1.65	1.4	1.18
Long Term Investments
Other Long Term Assets
Total Assets	4.69	163	126	85.6	104
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	4.3	9.76	8.87	12.4	24.5
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	7.52	13.5	15.1	17.2	27.4
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-2.82	149	111	68.5	76.5
Total Liabilities & Shareholders' Equity	4.69	163	126	85.6	104
Total Common Shares Outstanding